When Dan Weissman worked at Goldman Sachs Group Inc. and, later, at a hedge fund, he didn’t have to worry about methamphetamine addicts chasing his employees with metal pipes. Or SWAT teams barging into his workplace looking for arsonists.
The reason Gus Christensen looks like an investment banker is that he was one until four months ago. A handshake reveals a shirt monogram over the wrist, an Omega watch and lapis cuff links he got on a JPMorgan Chase & Co. trip to Chile.
Along an Alpine fairway veiled between the private banks of Geneva and the lakefront estates of their jumpy Swiss depositors, Jean-Noel Bioul taps his wrist and offers clients the ultimate in luxury shielding for perilous economic times.
At the wireless industry's biggest annual show in Barcelona, executives weren't afraid to ditch their Rolexes for plastic alternatives -- from smartwatches to connected bracelets. Carlo Ferro, finance chief at chipmaker STMicroelectronics, sported two.
Tom Perkins may be able to buy a six-pack of Rolexes with the millions he made as a pioneering venture capitalist, but if he were an executive in the technology industry today, he could easily afford a boatload of luxury watches.
Access to cheaper drugs in other countries may be limited by a provision sought by the U.S. in a Pacific trade deal, according to patent specialists who reviewed a document exposed by the WikiLeaks anti-secrecy group.